Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals SBC expense by award type — Stock options
SBC expense by award type — Stock options ($M) ($M)
Vertex Pharmaceuticals SBC expense by award type — Stock options: $2.20M in Q2 2026, up 83.3% from a year earlier.
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K Note (Stock-based Compensation).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Vertex Pharmaceuticals SBC expense by award type — Stock options ($M), quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/sbc-by-type-opt
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.